Leadership Overview
Insulet has 9 executives leading key functions including strategy, finance, operations, human resources, and technology.
Driven by innovation, Insulet is dedicated to simplifying the lives of individuals managing diabetes and other conditions through its advanced Omnipod product platform, significantly impacting global health outcomes.
Driven by innovation, Insulet is dedicated to simplifying the lives of individuals managing diabetes and other conditions through its advanced Omnipod product platform, significantly impacting global health outcomes.
Leadership Roles at Insulet
Ashley McEvoy - President, Chief Executive Officer & Director
Ashley McEvoy, the President, Chief Executive Officer & Director at Insulet, directs the company's overarching strategy and operational execution. This leadership role involves guiding Insulet's mission to enhance the lives of individuals with diabetes through its Omnipod Insulin Management System. McEvoy oversees the development and expansion of the Omnipod technology platform, ensuring its application across new therapeutic areas for non-insulin subcutaneous drug delivery. The Chief Executive Officer drives corporate vision, fostering innovation and ensuring alignment with market demands. This executive's responsibilities encompass stakeholder relations, financial performance oversight, and long-term growth initiatives. By championing the unique, wearable design of the Omnipod, Ashley McEvoy ensures Insulet maintains its position as a leader in innovative diabetes care solutions.

Sagar Patel - Chief of Staff & Chief Executive Officer, Office
Sagar Patel, the Chief of Staff & Chief Executive Officer, Office at Insulet, provides strategic support and operational coordination across executive functions. This role involves managing key initiatives, facilitating cross-departmental communication, and ensuring alignment with the company's strategic objectives. Patel works closely with the Chief Executive Officer to drive operational efficiency and execute critical projects related to the Omnipod product platform. The Chief of Staff position is vital for streamlining operations and enhancing decision-making processes. By optimizing the CEO's office functions, Sagar Patel directly contributes to Insulet's ability to deliver innovative medical devices that simplify life for individuals managing diabetes and other conditions.
Carsten Boess - Chief Financial Officer
Carsten Boess, the Chief Financial Officer at Insulet, manages the company's financial operations and strategic fiscal planning. This role involves overseeing all aspects of financial reporting, budgeting, and capital allocation to support Insulet's growth objectives. The Chief Financial Officer ensures robust financial controls and compliance with regulatory requirements, safeguarding the company's assets. Boess's responsibilities extend to managing investor relations and securing funding to advance the development and commercialization of the Omnipod product platform. By optimizing financial strategies, Carsten Boess directly contributes to the company's ability to deliver innovative medical devices that simplify life for people with diabetes and other conditions.
Timothy Stonesifer - Chief Financial Officer, At Alcon Inc
Timothy Stonesifer, the Chief Financial Officer, At Alcon Inc, directs financial strategy and operations. This executive role involves comprehensive oversight of fiscal planning, resource allocation, and financial performance management. Stonesifer's responsibilities include ensuring financial integrity, driving profitability, and supporting strategic growth initiatives within the organization. The Chief Financial Officer role demands a deep understanding of market dynamics and capital management to achieve corporate objectives. By implementing sound financial policies, Timothy Stonesifer contributes to the sustained success and operational efficiency of the company.
Flavia Pease - Executive VP & Chief Financial Officer
Flavia Pease, the Executive VP & Chief Financial Officer at Insulet, spearheads the company's financial direction and fiscal health. This senior leadership position encompasses managing all financial activities, including accounting, treasury, and financial planning and analysis, to support Insulet's innovative medical device development. Pease ensures rigorous financial discipline and compliance, driving strategic investments in the Omnipod platform and its expansion into new therapeutic areas. The Executive Vice President & Chief Financial Officer role is critical in optimizing capital structure and fostering investor confidence. Through astute financial management, Flavia Pease directly enables Insulet's commitment to simplifying life for individuals managing chronic conditions.

Ana Chadwick - Executive Vice President & Chief Financial Officer & Treasurer
Ana Chadwick, the Executive Vice President & Chief Financial Officer & Treasurer at Insulet, commands the company's financial strategy and treasury functions. This pivotal role involves overseeing all financial operations, including accounting, reporting, and capital management, to fuel Insulet's innovation in diabetes care and beyond. Chadwick ensures robust financial governance and optimizes the company's liquidity and funding strategies to support the Omnipod product platform's global reach. The Executive Vice President & Chief Financial Officer & Treasurer position requires strategic foresight in managing financial risks and opportunities. By directing treasury operations and financial planning, Ana Chadwick reinforces Insulet's capacity to deliver life-enhancing medical devices.

Charles Alpuche - Chief Operating Officer & Vice Executive
Charles Alpuche, the Chief Operating Officer & Vice Executive at Insulet, directs the company's operational strategies and execution. This leadership role involves overseeing manufacturing, supply chain, and global operations to ensure the efficient production and delivery of Insulet's Omnipod Insulin Management System. Alpuche focuses on optimizing operational processes, driving efficiency, and maintaining high-quality standards across all manufacturing facilities. The Chief Operating Officer position is essential for scaling production to meet global demand for innovative diabetes care solutions. By enhancing operational performance, Charles Alpuche directly supports Insulet's commitment to making life easier for individuals managing diabetes and other conditions.
Nikkole DeMars - Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX)
Nikkole DeMars, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) at Insulet, orchestrates end-to-end customer experience initiatives. This position focuses on planning and operationalizing strategies that enhance customer satisfaction and engagement with Insulet's Omnipod product platform. DeMars works closely with the GVP of E2E CX to ensure seamless customer journeys, from product adoption to ongoing support. The Chief of Staff role involves driving cross-functional collaboration to optimize operational efficiency and customer service delivery. By refining CX planning and operations, Nikkole DeMars directly supports Insulet's mission to make life easier for individuals managing diabetes and other conditions through innovative technology.
Rakesh Pant - Staff Software Engineer & Chief Technology Officer, Cloud Data Products
Rakesh Pant, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products at Insulet, leads the technological vision and development for cloud-based data solutions. This role focuses on architecting and implementing robust cloud infrastructure to support Insulet's data-driven initiatives, particularly concerning the Omnipod product platform. Pant oversees the engineering teams responsible for cloud data product development, ensuring scalability, security, and performance. The Chief Technology Officer, Cloud Data Products position is crucial for leveraging data analytics to enhance product offerings and operational efficiency. By driving innovation in cloud data technologies, Rakesh Pant directly contributes to Insulet's mission of improving patient outcomes through advanced medical devices.
Elizabeth Davis - Senior VP & Chief Human Resources Officer
Elizabeth Davis, the Senior VP & Chief Human Resources Officer at Insulet, leads the company's human capital strategy and organizational development. This executive role focuses on attracting, retaining, and developing top talent to support Insulet's mission of innovation in diabetes care and beyond. Davis oversees all HR functions, including talent acquisition, compensation and benefits, employee relations, and fostering a positive corporate culture. The Chief Human Resources Officer position is critical for building a high-performing workforce capable of driving the development and commercialization of the Omnipod product platform. By championing employee growth and engagement, Elizabeth Davis ensures Insulet has the skilled personnel necessary to advance its life-enhancing medical technologies.

Explore Leadership Teams in Manufacturing
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership SE
CS
Medicom was founded in 1988. This company provides infection control product manufacturing. Their headquarters are located in Beaconsfield, Quebec, Canada.
Company Leadership MH
BM
MH
JM
STERIS plc, founded in 1985 and headquartered in Leicester, United Kingdom, is a global leader in medical manufacturing that develops and markets infection prevention, contamination control, and sterilization products and services. The company provides specialized solutions for healthcare, pharmaceutical, scientific research, industrial, and governmental customers worldwide. STERIS offers a comprehensive range of products including sterilizers, surgical tables, examination lights, operating room equipment, gastrointestinal devices, and cleaning systems. Additionally, the company delivers outsourced services for hospitals and healthcare facilities, including equipment maintenance, sterilization management, and process improvement consulting. Through its network of facilities across multiple continents, STERIS provides contract sterilization services using various technologies such as gamma radiation, electron beam, X-ray, and ethylene oxide gas, along with laboratory testing and validation services.
Company Leadership
MH
WP
PB
Founded in 1899, Dentsply Sirona is a manufacturer of professional dental products and technologies. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a portfolio of brands. Dentsply Sironas global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria.
Company Leadership
MP

DC